Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $30.7700 (-1.54%) ($30.5100 - $34.3000) on Mon. Mar. 14, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.89% (three month average) | RSI | 67 | Latest Price | $30.7700(-1.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -4.9% a day on average for past five trading days. | Weekly Trend | EDIT advances 10.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(59%) IBB(58%) XBI(57%) IWO(54%) ARKK(53%) | Factors Impacting EDIT price | EDIT will decline at least -5.445% in a week (0% probabilities). VIXM(-14%) TLT(-6%) SHY(-6%) GDXJ(-5%) IPO(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.445% (StdDev 10.89%) | Hourly BBV | 0 () | Intraday Trend | -1.5% | | | |
|
5 Day Moving Average | $32.37(-4.94%) | 10 Day Moving Average | $33.43(-7.96%) | 20 Day Moving Average | $27.91(10.25%) | To recent high | -26.7% | To recent low | 140.2% | Market Cap | $1.911b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |